Hyponatremia clinical trials
The registry lists 164 studies for Hyponatremia across more than 10 countries. 16 are recruiting or about to start. 118 of them are mainly about Hyponatremia (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-30.
Get an email when these change. Save the Hyponatremia studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
University Hospital, Basel, Switzerland (13) · Cumberland Pharmaceuticals (9) · Otsuka Pharmaceutical Development & Commercialization, Inc. (8) · Sanofi (6) · University of Cologne (6) · Korea Otsuka Pharmaceutical Co., Ltd. (3) · Otsuka Pharmaceutical Europe Ltd (3) · Hospital Italiano de Buenos Aires (3)
What is being tested here
Drugs under test in Hyponatremia studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 4
- Apr 2027Validation of New Diagnostic Indices to Simplify Hyponatremia Therapy Assessment in Patients on Thiazide Diuretics · University Hospital, Basel, Switzerland
- Apr 2027Protein Supplementation in Hyponatremia Due to the Syndrome of Inappropriate Antidiuresis · University Hospital, Basel, Switzerland
- Oct 2027Natriuresis-guided Depletion After Cardiac Surgery · Centre Hospitalier Universitaire, Amiens
- Nov 2027Urea for Treatment of Hyponatremia in Patients With SIAD Unresponsive to Fluid Restriction · University of Turin, Italy
Who these studies take
Of the 14 Hyponatremia studies recruiting now, 13 (93%) set no upper age limit and 0 (0%) stop at 75 or younger. 1 (7%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 1 (7%) | 1 (7%) |
| 18 | 14 (100%) | 14 (100%) |
| 30 | 14 (100%) | 14 (100%) |
| 40 | 14 (100%) | 14 (100%) |
| 50 | 14 (100%) | 14 (100%) |
| 65 | 14 (100%) | 14 (100%) |
| 75 | 14 (100%) | 14 (100%) |
| 85 | 14 (100%) | 14 (100%) |
Across all 164 studies, recruiting or not: 21% stop at 75 or younger and 17% at 65; 17% take children; 2% are for women only and 3% for men only; 14% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Hyponatremia studies take
Of 24 interventional studies with no phase under Hyponatremia, half reached primary completion within 24 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Interventional, no phase | 24 mo12–48 · 24 studies | — | — |
| Observational | 32 mo12–59 · 18 studies | — | — |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
Studies
Recruiting first, then most recently updated. Showing 50 of 164. Browse all 164 → or search them.
- Systematic Use of DDAVP to Prevent Serum Sodium Overcorrection in Severe HyponatremiaRecruitingNCT06020495Phase 31 country
- Urea for Treatment of Hyponatremia in Patients With SIAD Unresponsive to Fluid RestrictionRecruitingNCT07528365Not applicable1 country
- Validation of New Diagnostic Indices to Simplify Hyponatremia Therapy Assessment in Patients on Thiazide DiureticsRecruitingNCT06381934Not applicable1 country
- Effect of Protein Supplementation and Fluid Restriction on Plasma Sodium Levels in Patients Undergoing Pituitary SurgeryRecruitingNCT07273630Not applicable1 country
- CReep and Maintenance flUid Sodium Chloride ADministration rEduction in cRitically Ill adultSRecruitingNCT07189091Phase 41 country
- Natriuresis-guided Depletion After Cardiac SurgeryRecruitingNCT07077772Not applicable1 country
- Regulation of Extracellular Sodium in End Stage Renal Disease Upon Volume and Electrolyte ChallengesRecruitingNCT06408077Not applicable1 country
- Evaluation of Volume and Electrolyte Balance in Hyponatremia Treatment - a Prospective Observational TrialRecruitingNCT056927261 country
- Protein Supplementation in Hyponatremia Due to the Syndrome of Inappropriate AntidiuresisRecruitingNCT06821802Not applicable1 country
- Urinary Prostaglandin as a Potential Predictive Marker for Thiazide-induced HyponatremiaRecruitingNCT055420562 countries
- Phase 2a Study for PK/PD of nC-001Not yet recruitingNCT06798675Phase 2
- Saline Infusion Test in HyponatremiaNot yet recruitingNCT06498856
- Low-dose Tolvaptan for Inpatient Hyponatraemia.RecruitingNCT061711001 country
- Prevalence of Hyponatremia in Dengue Infected Patients: Relationship With Systemic Inflammation.RecruitingNCT061095321 country
- Plasma Sodium and Sodium Administration in the ICURecruitingNCT060379281 country
- Study of Changes in CSF Ionic Composition After Aneurysmal Meningeal HemorrhageRecruitingNCT059427551 country
- Effects of the SGLT2 Inhibitor Empagliflozin in Patients With Euvolemic and Hypervolemic HyponatremiaCompletedNCT04447911Phase 43 countries
- Establishment of an Algorithm for a Clinical Classfication of Hypoosmolar HyponatremiaCompletedNCT005419441 country
- "SALT Trial" Study of Ascending Levels of Tolvaptan in HyponatremiaCompletedNCT00072683Phase 31 country
- Study of Ascending Levels of Tolvaptan in HyponatremiaCompletedNCT00201994Phase 31 country
- Analysis of the Epidemiology, Clinical Presentation and Therapy as Well as Therapy-associated Risk of Demyelination Syndrome in Patients With Profound Hyponatremia in the Emergency DepartmentCompletedNCT067817101 country
- Hyponatremia in the Elderly: Benefit From a Change in Drug Therapy?CompletedNCT01212211Not applicable1 country
- Hyponatremia - Complications, Prognosis, Epidemiology in Finnish Tertiary CareActive, not recruitingNCT074307871 country
- Retrospective Analysis of ECG Changes and Arrhythmias in Patients With Profound HyponatremiaCompletedNCT072558331 country
- Targeted Correction of Plasma Sodium Levels in Hospitalized Patients With HyponatremiaCompletedNCT03557957Not applicable5 countries
- Influence of Serum Sodium Levels on Bone Metabolism and Turnover in Hospitalized PatientsCompletedNCT042273011 country
- Urea Therapy for Hyponatremia in Subarachnoid HemorrhageActive, not recruitingNCT04552873Not applicable1 country
- Effects of Intravenous [Pyr1]Apelin-13 on Healthy Volunteers With Artificially Induced SIADCompletedNCT06277336Not applicable1 country
- Delirium Related to Proton Pump Inhibitors UseCompletedNCT058155501 country
- A Phase 2 Efficacy and Safety Study of the Tolvaptan Tablets in Patients With Non-hypovolemic Non-acute HyponatremiaCompletedNCT00664014Phase 21 country
- Specified Drug Use-results Survey (Long-term Use) on MINIRINMELT® OD Tablet (Nocturia)CompletedNCT043299751 country
- Hyponatremia Volume Status Analysis by Point-of-care UltrasoundActive, not recruitingNCT060138001 country
- Mortality and Neurologic Outcomes in Rapid vs. Slow Hyponatremia CorrectionCompletedNCT066755911 country
- Boluses of Ringer's in Surgical Kids (BRiSK Study)CompletedNCT05285371Early Phase 11 country
- Hyponatremia Study (Delayed Hyponatremia After Pituitary Surgery)CompletedNCT03636568Not applicable1 country
- Comparison of Isotonic Versus Hypotonic Fluids in Neonates for Maintenance Fluid Therapy After SurgeryCompletedNCT06484608Not applicable1 country
- Urea for Chronic HyponatremiaTerminatedNCT04588207Phase 21 country
- Colloid Osmotic Pressure and Osmolality in HyponatremiaTerminatedNCT037037131 country
- Effects of Oral Salt Supplementation on Physical Performance During a Half-ironmanCompletedNCT02103491Not applicable1 country
- Comparison of the Isotonic and Hypotonic Intravenous Maintenance Fluids In Term Newborns: Neofluid StudyCompletedNCT047813611 country
- Analysis of Factors Determining Increase of Serum Sodium in Hyponatremic PatientsCompletedNCT052775841 country
- Effect of Protein Supplementation on Plasma Sodium Levels and Urinary Urea Excretion in Patients With SIADCompletedNCT04987385Not applicable1 country
- Changes in Serum Creatinine Levels Can Help Distinguish Hypovolemic From Euvolemic HyponatremiaCompletedNCT047449871 country
- Validation of Capillary Serum Sodium LevelsCompletedNCT05414279Not applicable1 country
- Relation Between COVID-19 Pts and Hyponatremia in Adreno Ortical Insufficient Patients.Status unknownNCT05408481
- Characterisation of Neuropsychological and Motoric Performance in Patients With HyponatremiaCompletedNCT01879774Not applicable3 countries
- Prevalence, Severity, Risk Factors, and Prognostic Value of Hyponatremia in Patients With Traumatic Brain InjuryStatus unknownNCT053010491 country
- Use of Conivaptan (Vaprisol) for Hyponatremic Neuro-ICU PatientsTerminatedNCT00727090Phase 4
- Effect of Samsca on Control of Hyponatremia and Extracellular Fluid in Cirrhotic Patients With AscitesTerminatedNCT01552590Phase 41 country
- Introduction of Hypo-osmolar ORS for Routine UseCompletedNCT00244777Phase 41 country